BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 24428625)

  • 21. Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008.
    Højfeldt SG; Wolthers BO; Tulstrup M; Abrahamsson J; Gupta R; Harila-Saari A; Heyman M; Henriksen LT; Jónsson ÒG; Lähteenmäki PM; Lund B; Pruunsild K; Vaitkeviciene G; Schmiegelow K; Albertsen BK;
    Br J Haematol; 2019 Feb; 184(3):405-417. PubMed ID: 30450575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensified PEG-L-asparaginase and antimetabolite-based therapy for treatment of higher risk precursor-B acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Salzer WL; Devidas M; Shuster JJ; Wang C; Chauvenet A; Asselin BL; Camitta BM; Kurtzberg J;
    J Pediatr Hematol Oncol; 2007 Jun; 29(6):369-75. PubMed ID: 17551397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful use of octreotide as a chemoprotectant for prevention of PEG-asparaginase-induced pancreatitis.
    Buie LW; Moore J; van Deventer H
    Pharmacotherapy; 2014 Aug; 34(8):e149-51. PubMed ID: 25112526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptomatic severe hypertriglyceridaemia with asparaginase therapy in acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma: is rechallenging safe?
    Lashkari HP; Lancaster D; Atra A; Champion MP; Taj MM
    Int J Hematol; 2011 Dec; 94(6):571-5. PubMed ID: 22057510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting asparaginase-associated pancreatitis.
    Knoderer HM; Robarge J; Flockhart DA
    Pediatr Blood Cancer; 2007 Oct; 49(5):634-9. PubMed ID: 16937362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical summary of pediatric acute lymphoblastic leukemia patients complicated with asparaginase-associated pancreatitis in SCCLG-ALL-2016 protocol.
    Wang J; Jia WG; Yang LH; Kuang WY; Huang LB; Chen HQ; Wang LN; Zhou DH; Liao N
    Hematology; 2023 Dec; 28(1):2171723. PubMed ID: 36752506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk Factors for Asparaginase-associated Pancreatitis: A Systematic Review.
    Oparaji JA; Rose F; Okafor D; Howard A; Turner RL; Orabi AI; Byersdorfer C; Mi Q; Ritchey K; Lowe ME; Husain SZ
    J Clin Gastroenterol; 2017; 51(10):907-913. PubMed ID: 28375864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Advances on the role of pegaspargase in the treatment of childhood leukemia].
    Liu L; Xie XT
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):155-60. PubMed ID: 24568909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New possibilities of treatment with PEG-L-asparaginase in patients with acute lymphoblastic leukemia sensitized to l-asparaginase E.coli and erwinase].
    Sikorska-Fic B; Makowska K; Rokicka-Milewska R
    Wiad Lek; 1998; 51 Suppl 4():233-6. PubMed ID: 10731974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peg-asparaginase for acute lymphoblastic leukemia.
    Rytting M
    Expert Opin Biol Ther; 2010 May; 10(5):833-9. PubMed ID: 20345338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute pancreatitis in children with acute lymphoblastic leukemia correlates with L-asparaginase dose intensity.
    Chen CB; Chang HH; Chou SW; Yang YL; Lu MY; Jou ST; Chen HL; Ni YH; Lin DT; Chang MH; Wu JF
    Pediatr Res; 2022 Aug; 92(2):459-465. PubMed ID: 34718353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia.
    Sahu S; Saika S; Pai SK; Advani SH
    Pediatr Hematol Oncol; 1998; 15(6):533-8. PubMed ID: 9842647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia.
    Hawkins DS; Park JR; Thomson BG; Felgenhauer JL; Holcenberg JS; Panosyan EH; Avramis VI
    Clin Cancer Res; 2004 Aug; 10(16):5335-41. PubMed ID: 15328169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity as a predictor of treatment-related toxicity in children with acute lymphoblastic leukaemia.
    Egnell C; Heyman M; Jónsson ÓG; Raja RA; Niinimäki R; Albertsen BK; Schmiegelow K; Stabell N; Vaitkeviciene G; Lepik K; Harila-Saari A; Ranta S
    Br J Haematol; 2022 Mar; 196(5):1239-1247. PubMed ID: 34726257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
    Top PC; Tissing WJ; Kuiper JW; Pieters R; van Eijck CH
    Pediatr Blood Cancer; 2005 Jan; 44(1):95-7. PubMed ID: 15368548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia.
    Gottschalk Højfeldt S; Grell K; Abrahamsson J; Lund B; Vettenranta K; Jónsson ÓG; Frandsen TL; Wolthers BO; Marquart HV; Vaitkeviciene G; Lepik K; Heyman M; Schmiegelow K; Albertsen BK
    Blood; 2021 Apr; 137(17):2373-2382. PubMed ID: 33150360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the Nordic Society of Paediatric Haematology and Oncology.
    Ranta S; Tuckuviene R; Mäkipernaa A; Albertsen BK; Frisk T; Tedgård U; Jónsson ÓG; Pruunsild K; Gretenkort Andersson N; Winther Gunnes M; Saulyte Trakymiene S; Frandsen T; Heyman M; Ruud E; Helgestad J
    Br J Haematol; 2015 Feb; 168(4):547-52. PubMed ID: 25288392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.
    Christ TN; Stock W; Knoebel RW
    J Oncol Pharm Pract; 2018 Jun; 24(4):299-308. PubMed ID: 28355969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of polyethylene glycol conjugated asparaginase and L-asparaginase for treatment of childhood acute lymphoblastic leukemia].
    Cooperation Group of Phase II Clinical Trial of PEG-Asp
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):29-33. PubMed ID: 18512312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries.
    Albertsen BK; Schrøder H; Jakobsen P; Müller HJ; Carlsen NT; Schmiegelow K
    Br J Clin Pharmacol; 2001 Oct; 52(4):433-7. PubMed ID: 11678787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.